WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2009141264) GALLIDERMIN TO TREAT INFECTIONS OF THE RESPIRATORY TRACT
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2009/141264    International Application No.:    PCT/EP2009/055852
Publication Date: 26.11.2009 International Filing Date: 14.05.2009
IPC:
A61K 38/16 (2006.01)
Applicants: BOEHRINGER INGELHEIM VETMEDICA GMBH [DE/DE]; Binger Str. 173 55216 Ingelheim am Rhein (DE) (For All Designated States Except US).
MUELLNER, Hubert [DE/DE]; (DE) (For US Only).
BOUYSSOU, Thierry [FR/DE]; (DE) (For US Only).
DAEMMGEN, Juergen [DE/DE]; (DE) (For US Only).
DISSE, Bernd [DE/DE]; (DE) (For US Only)
Inventors: MUELLNER, Hubert; (DE).
BOUYSSOU, Thierry; (DE).
DAEMMGEN, Juergen; (DE).
DISSE, Bernd; (DE)
Agent: HAMMANN, Heinz; (DE)
Priority Data:
08156561.6 20.05.2008 EP
Title (EN) GALLIDERMIN TO TREAT INFECTIONS OF THE RESPIRATORY TRACT
(FR) GALLIDERMINE POUR TRAITER LES INFECTIONS DE L’APPAREIL RESPIRATOIRE
Abstract: front page image
(EN)The present invention lies in the field of the treatment and prophylaxis of infectious diseases. It relates to the prophylaxis and treatment of bacterial infections of the respiratory tract caused by gram-positive bacteria or other susceptible bacterial pathogens in a patient, comprising the lantibiotic Gallidermin or a pharmaceutically active variant thereof as active substance, and related subject matters.
(FR)La présente invention concerne le traitement et la prophylaxie des maladies infectieuses. Elle concerne la prophylaxie et le traitement des maladies infectieuses de l’appareil respiratoire provoquées par les bactéries à Gram positif ou par d’autres bactéries pathogènes sensibles chez un patient, comprenant un antibiotique, la gallidermine, ou une de ses variantes pharmaceutiquement actives en tant que principe actif et l’invention concerne aussi des sujets connexes.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)